Core Biology Areas
Over the course of our prior drug discovery experiences, our R&D team has accumulated and developed a specialized understanding and track record within multiple such core biology areas and have been closely following the emerging research. We are fully leveraging our computational platform to enable the rigorous and comprehensive analyses of both validated and newer targets within these core areas, enabling discovery of innovative therapeutics and development strategies and subsequent translation into clinical areas with high or unmet need.
We are currently actively pursuing discover programs in innate immunity, DNA damage repair, RNA modification & metabolism, and transcriptional & translational control. In each of these focused core biology areas, we are taking specific approaches that are uniquely available to us, including the use of novel allosteric site modifiers or recently established chemical tools such as peptides and related molecules.
Through this new approach, we are making significant progress toward delivery of innovative therapeutics and their subsequent translation into various clinical areas with high unmet need including oncology / immuno-oncology, chronic inflammation-related diseases, and rare intractable disorders.